MRNS

Marinus Pharmaceuticals (MRNS)

Marinus Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MRNS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/08	20 : 07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/05/08	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/05/08	20 : 00	Business Wire	Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/05/02	21 : 00	Business Wire	Marinus Pharmaceuticals to Present at the RBC Capital Markets 2024 Global Healthcare Conference	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/05/01	21 : 00	Business Wire	Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2024 Financial Results on May 8, 2024	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/04/15	20 : 00	Business Wire	Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/04/06	05 : 00	Business Wire	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/03/27	21 : 41	Business Wire	Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/03/06	06 : 14	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/03/06	06 : 01	Business Wire	Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/23	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/22	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/22	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/22	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/21	21 : 00	Business Wire	Marinus Pharmaceuticals to Present at Upcoming Investor Conferences	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/20	21 : 00	Business Wire	Marinus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/17	06 : 00	Business Wire	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/15	06 : 18	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/15	05 : 07	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/15	02 : 18	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/15	00 : 06	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/14	23 : 04	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/02/14	02 : 13	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/01/20	06 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/01/20	06 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/01/20	06 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/01/20	06 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/01/20	06 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/01/20	06 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNS	Marinus Pharmaceuticals Inc
2024/01/20	06 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRNS	Marinus Pharmaceuticals Inc